Safety observations in neuroblastoma patients undergoing 18F-mFBG PET
In this investigation of the potential clinical utility of m FBG PET imaging, no significant adverse safety signals were noted. Two mild, self-limited AEs were observed, without associated changes in vital signs. No grade 2 or higher AEs were noted. The findings are consistent with a favorable safety profile for m FBG in the target population of patients with neuroblastoma.
Authors
- Neeta D. Pandit-Taskar (ORCID: https://orcid.org/0000-0003-1551-2036)
- Ellen M. Basu (ORCID: https://orcid.org/0000-0002-4555-220X)
- P. David Mozley (ORCID: https://orcid.org/0000-0002-1651-4212)
- Shakeel I. Modak (ORCID: https://orcid.org/0000-0002-7280-1726)
- Arnold Jacobson
- Eloisa Balquin
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1097/mnm.0000000000001938
- Citations
- 2
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.74